Use of Propafenone for the Prevention of Ventricular Hyperkinetic Arrhythmias in the Mitral Valve Prolapse Syndrome

  • F. Furlanello
  • G. B. Durante
  • P. Dal Forno
  • L. Frisanco
  • G. Mosna
  • R. Bettini
  • M. Disertori
  • G. Vergara
  • A. Del Favero
  • E. Stirpe
Conference paper

Abstract

Sudden death has been reported to occurr in 1,4% of patients suffering from mitral valve prolapse (MVP). Ventricular hyperkinetic arrhythmias (VHA), also potentially malignant, are found in a substantial number of patients suffering from this syndrome. Thus effective antiarrhythmic treatment is necessary.

Keywords

Myopathy Propafenone 

References

  1. Disertori M, Vergara G, Dal Forno P, Inama G, Furlanello F (1981) Le Nuove Frontière délie Aritmie Piccin p. 213Google Scholar
  2. Swartz MH et al. (1977) Am J Med 62: 377PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • F. Furlanello
  • G. B. Durante
  • P. Dal Forno
  • L. Frisanco
  • G. Mosna
  • R. Bettini
  • M. Disertori
  • G. Vergara
  • A. Del Favero
  • E. Stirpe

There are no affiliations available

Personalised recommendations